▎药明康德内容团队编辑强生（Johnson& Johnson）日前宣布，美国FDA已授予其靶向新生儿Fc受体（FcRn）的在研抗体疗法nipocalimab突破性疗法认定（BTD），用于治疗中度至重度干燥综合征（Sjögren’s ...

ZHUHAI, Guangdong, Nov. 12 (Xinhua) -- China's independently-developed AS700 civil manned airship has secured 10 more purchase orders, ready for commercial operations, according to its developer - the ...